The U.S. Food and Drug Administration granted approval of Endo International’s Qwo (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women. QWO is the first FDA-approved injectable treatment for cellulite.

ANI Pharmaceuticals to Acquire Two NDAs from Merck for $75 Million – Transaction Highlights:– Corticotropin-zinc hydroxide, 40 units/mL, NDA #009854– Assets will be acquired by foreign subsidiary to achieve more favorable tax treatment for ANI– Acquisition significantly advances ANI’s core strategy of re-commercializing previously approved products– Conference call to discuss transaction scheduled today at 10:00am […]